ARCHIVES

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

MSKCC Wins Zoning Request For New Labs.

February 8, 2002

Robert Young To Step Down As Fox Chase Cancer Center President in 2007.

September 29, 2006

New Guidelines Developed For Cooperative Group Grant Review

August 17, 1979

Utah, Hopkins Get Large Donations To Support Research

October 6, 1995

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

March 19, 1976

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006